Published in Atherosclerosis on November 01, 1991
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet (2008) 1.89
The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Genet (1997) 1.11
Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet (1996) 0.93
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet (1992) 0.92
Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Hum Genet (1998) 0.91
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet (1999) 0.89
The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest (1994) 0.86
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases. Cardiovasc Drugs Ther (2016) 0.86
Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study. Arterioscler Thromb Vasc Biol (2015) 0.82
Genetics of lipid traits and relationship to coronary artery disease. Curr Cardiol Rep (2013) 0.82
Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res (2015) 0.81
Segregation analysis of apolipoprotein A1 levels in families of adolescents: a community-based study in Taiwan. BMC Genet (2006) 0.78
Heritability of serum apolipoprotein concentrations in middle-aged Japanese twins. J Epidemiol (2009) 0.77
Polymorphisms in ApoB gene are associated with risk of myocardial infarction and serum ApoB levels in a Chinese population. Int J Clin Exp Med (2015) 0.75
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59
Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet (1979) 3.96
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Impact of diabetes on cardiac structure and function: the strong heart study. Circulation (2000) 3.56
The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47
Epidemiology of coronary heart disease: the Framingham study. Am J Med (1984) 3.38
Choice of an estimate of genetic variance from twin data. Am J Hum Genet (1974) 3.36
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol (1986) 3.35
NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23
Numerical studies on two-loci selection models with general viabilities. Theor Popul Biol (1975) 3.20
Calcium supplementation and increases in bone mineral density in children. N Engl J Med (1992) 3.13
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta (1987) 2.70
Ammonia as an Intermediate in Nitrogen Fixation by Azotobacter. J Bacteriol (1946) 2.68
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis (1989) 2.65
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
Growth Factor Requirements of the Root Nodule Bacteria. J Bacteriol (1939) 2.57
Occupational physical demands, knee bending, and knee osteoarthritis: results from the Framingham Study. J Rheumatol (1991) 2.56
Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol (1995) 2.53
On Photosynthesis and Free Nitrogen Assimilation by Leguminous Plants. Proc Natl Acad Sci U S A (1934) 2.50
Protective effect of fruits and vegetables on development of stroke in men. JAMA (1995) 2.50
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Biotin as a Growth Factor for Rhizobia. J Bacteriol (1942) 2.47
New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis (1997) 2.45
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med (1981) 2.42
Predictors of brain morphology for the men of the NHLBI twin study. Stroke (1999) 2.41
Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol (1998) 2.39
Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study. Am J Clin Nutr (1998) 2.38
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int (2001) 2.34
Sudden coronary death in women. Am Heart J (1998) 2.33
Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med (1999) 2.33
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol (1988) 2.32
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30
NITROGEN FIXATION BY CELL-FREE PREPARATIONS FROM MICROORGANISMS. Proc Natl Acad Sci U S A (1960) 2.28